Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase NA 15Phase 3 13Phase 1/2 4Phase 1 4Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Rectal Neoplasms 3Stomach Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Skin Neoplasms 1Sarcoma, Ewing 1Radiation Injuries 1Postoperative Complications 1Pilonidal Sinus 1Osteosarcoma 1Neoplasms 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Gestational Trophoblastic Disease 1Fatigue 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1

Interventions

Capecitabine 16Paclitaxel 12Docetaxel 10Cyclophosphamide 10Epirubicin 8Gemcitabine 7Letrozole 6Doxorubicin 6Carboplatin 6Trastuzumab 5Vinorelbine 4Cisplatin 4pertuzumab 3exemestane 3Neoadjuvant Therapy 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3130-nm albumin-bound paclitaxel 3apatinib 2Zoledronic Acid 2Thiotepa 2Taxes 2Tamoxifen 2Standard of Care 2Radiosurgery 2Melatonin 2Lapatinib 2Injections 2Goserelin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Breast Neoplasms × Surgical Procedures, Operative × Clear all
NCT02364557 2026-05-19

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

NRG Oncology

Phase 2/3 Completed
129 enrolled 23 charts
Breast

Breast Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡